Biotech | April 10, 2022
LivaNova initiates targeted commercial launch of Essenz patient monitor
An intuitive monitor featuring a patient-tailored approach is now in clinical use in select centres in U.S. and Europe
An intuitive monitor featuring a patient-tailored approach is now in clinical use in select centres in U.S. and Europe
Although PCM has advanced substantially in recent years, most of the valuable technical information resides with private companies and academic publications across multiple platforms
The company plans to file its NDA in China and MAA in the EU in 2022, making Hansizhuang potentially to be the world's first PD-1 inhibitor for the first-line treatment of SCLC
If authorized by the USFDA, the Proof Lab Test System may be used to deliver accurate, actionable, lab-quality results for Covid-19 in as little as 18 minutes
Under this initiative, 700 meals will be provided every day to four hospitals in Mumbai
The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Pradaxa Capsules of Boehringer lngelheim
The new reagents will bring the exceptional sensitivity of the company’s liquid format 1-step RT-qPCR reagents to a freeze-dryable format
Aveir VR is specifically designed to be retrieved when therapy needs to evolve or the device needs to be replaced
The two-day event will showcase achievements and address issues pertaining to the industry
If approved, it will be the first USFDA-approved immunomodulator for the treatment of Covid-19 in hospitalised patients
Subscribe To Our Newsletter & Stay Updated
